Nektar to Announce Financial Results for the Third Quarter 2021 on Thursday, November 4, 2021, After Close of U.S.-Based Financial Markets

Rhea-AI Summary

Nektar Therapeutics (NKTR) will announce its financial results for Q3 2021 on November 4, 2021, after U.S. markets close. CEO Howard Robin will lead a conference call to discuss the results at 5:00 p.m. ET. Interested parties can access the press release and the live audio webcast via their website. A replay of the conference call will be available until December 6, 2021. Nektar specializes in developing therapies in oncology, immunology, and virology, supported by a robust R&D pipeline.

Positive

• Scheduled announcement of Q3 financial results may provide insights into company's performance.
• Potential for increased investor interest during the earnings call.

Negative

• None.

SAN FRANCISCO, Oct. 26, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2021 on Thursday, November 4, 2021, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through December 6, 2021.

To access the conference call, follow these instructions:

Dial: (877) 881-2183 (U.S); (970) 315-0453 (international)
Conference ID: 8264398 (Nektar Therapeutics is the host)

About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-third-quarter-2021-on-thursday-november-4-2021-after-close-of-us-based-financial-markets-301409217.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar Therapeutics announce its Q3 2021 financial results?

Nektar Therapeutics will announce its Q3 2021 financial results on November 4, 2021.

What time is the conference call for Nektar's Q3 results?

The conference call will begin at 5:00 p.m. Eastern Time on November 4, 2021.

How can I access Nektar Therapeutics' Q3 earnings conference call?

You can access the conference call through a link on Nektar's website, or by dialing (877) 881-2183 for U.S. callers.

Is there a way to replay Nektar's Q3 financial results call?

Yes, the replay will be available until December 6, 2021.

What is the focus of Nektar Therapeutics' research and development?

Nektar Therapeutics focuses on investigational medicines in oncology, immunology, and virology.